Search research articles
Contact Us
Filters
Showing results (71-80 of 129) with videos related to
Page
of 13
Sort By:
Breast Cancer Research and Treatment
|
October 13, 2019
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials
Evandro de Azambuja, Noam Ponde, Marion Procter, et al.
The American Journal of Cardiology
|
March 19, 2011
Coronary bifurcation lesions treated with simple approach (from the Cordoba & Las Palmas [CORPAL] Kiss Trial)
Manuel Pan, Alfonso Medina, José Suárez de Lezo, et al.
International Journal of Cancer
|
November 5, 2020
STAT3 activation in HER2-positive breast cancers: Analysis of data from a large prospective trial
Amir Sonnenblick, Dominique Agbor-Tarh, Evandro de Azambuja, et al.
Journal of Oncology Practice
|
December 23, 2017
Alternative Outpatient Chemotherapy Scheduling Method to Improve Patient Service Quality and Nurse Satisfaction
Yu-Li Huang, Alan H Bryce, Tracy Culbertson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2019
Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31
Saranya Chumsri, Zhuo Li, Daniel J Serie, et al.
The Oncologist
|
April 21, 2022
Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance)
Kostandinos Sideras, David W Hillman, Karthik Giridhar, et al.
AJR. American Journal of Roentgenology
|
June 6, 2019
Comparison of <sup>99m</sup>Tc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy
Katie N Hunt, Amy Lynn Conners, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2015
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)
Hope S Rugo, William T Barry, Alvaro Moreno-Aspitia, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
November 11, 2011
A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans
Gerardo Colon-Otero, Monica Albertie, Mary Lesperance, et al.
Breast Cancer Research and Treatment
|
September 20, 2020
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D)
Noam Pondé, Dominique Agbor-Tarh, Lissandra Dal Lago, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 129) with videos related to
Sort By:
Page
of 13
Breast Cancer Research and Treatment
|
October 13, 2019
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials
Evandro de Azambuja, Noam Ponde, Marion Procter, et al.
The American Journal of Cardiology
|
March 19, 2011
Coronary bifurcation lesions treated with simple approach (from the Cordoba & Las Palmas [CORPAL] Kiss Trial)
Manuel Pan, Alfonso Medina, José Suárez de Lezo, et al.
International Journal of Cancer
|
November 5, 2020
STAT3 activation in HER2-positive breast cancers: Analysis of data from a large prospective trial
Amir Sonnenblick, Dominique Agbor-Tarh, Evandro de Azambuja, et al.
Journal of Oncology Practice
|
December 23, 2017
Alternative Outpatient Chemotherapy Scheduling Method to Improve Patient Service Quality and Nurse Satisfaction
Yu-Li Huang, Alan H Bryce, Tracy Culbertson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2019
Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31
Saranya Chumsri, Zhuo Li, Daniel J Serie, et al.
The Oncologist
|
April 21, 2022
Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance)
Kostandinos Sideras, David W Hillman, Karthik Giridhar, et al.
AJR. American Journal of Roentgenology
|
June 6, 2019
Comparison of <sup>99m</sup>Tc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy
Katie N Hunt, Amy Lynn Conners, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2015
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)
Hope S Rugo, William T Barry, Alvaro Moreno-Aspitia, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
November 11, 2011
A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans
Gerardo Colon-Otero, Monica Albertie, Mary Lesperance, et al.
Breast Cancer Research and Treatment
|
September 20, 2020
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D)
Noam Pondé, Dominique Agbor-Tarh, Lissandra Dal Lago, et al.
Page
of 13